$84.75
1.41% yesterday
Nasdaq, May 20, 10:00 pm CET
ISIN
US5255582018
Symbol
LMAT

LeMaitre Vascular, Inc. Stock price

$84.75
+0.03 0.04% 1M
-18.69 18.07% 6M
-7.39 8.02% YTD
+5.36 6.75% 1Y
+39.95 89.17% 3Y
+59.38 234.06% 5Y
+74.57 732.51% 10Y
Nasdaq, Closing price Tue, May 20 2025
-1.21 1.41%
ISIN
US5255582018
Symbol
LMAT
Sector

Key metrics

Market capitalization $1.91b
Enterprise Value $1.80b
P/E (TTM) P/E ratio 42.86
EV/FCF (TTM) EV/FCF 43.72
EV/Sales (TTM) EV/Sales 7.95
P/S ratio (TTM) P/S ratio 8.46
P/B ratio (TTM) P/B ratio 5.51
Dividend yield 0.76%
Last dividend (FY24) $0.64
Revenue growth (TTM) Revenue growth 13.19%
Revenue (TTM) Revenue $226.26m
EBIT (operating result TTM) EBIT $53.07m
Free Cash Flow (TTM) Free Cash Flow $41.12m
Cash position $302.55m
EPS (TTM) EPS $1.98
P/E forward 39.35
P/S forward 7.80
EV/Sales forward 7.32
Short interest 7.72%
Show more

Is LeMaitre Vascular, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,789 stocks worldwide.

LeMaitre Vascular, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

11 Analysts have issued a LeMaitre Vascular, Inc. forecast:

5x Buy
45%
6x Hold
55%

Analyst Opinions

11 Analysts have issued a LeMaitre Vascular, Inc. forecast:

Buy
45%
Hold
55%

Financial data from LeMaitre Vascular, Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
226 226
13% 13%
100%
- Direct Costs 75 75
3% 3%
33%
151 151
19% 19%
67%
- Selling and Administrative Expenses 73 73
23% 23%
32%
- Research and Development Expense 16 16
9% 9%
7%
63 63
25% 25%
28%
- Depreciation and Amortization 9.78 9.78
2% 2%
4%
EBIT (Operating Income) EBIT 53 53
30% 30%
23%
Net Profit 45 45
33% 33%
20%

In millions USD.

Don't miss a Thing! We will send you all news about LeMaitre Vascular, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

LeMaitre Vascular, Inc. Stock News

Neutral
GlobeNewsWire
15 days ago
BURLINGTON, Mass., May 05, 2025 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that David Roberts, President, will present at the Bank of America Securities 2025 Healthcare Conference on Tuesday, May 13, 2024, at 5:00 PM PDT at the Encore at the Wynn Hotel in Las Vegas, NV.
Neutral
Seeking Alpha
19 days ago
LeMaitre Vascular, Inc. (LMAT) Q1 2025 Earnings Call Transcript
Neutral
GlobeNewsWire
19 days ago
BURLINGTON, Mass., May 01, 2025 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq: LMAT), a provider of vascular devices, implants, and services, today reported Q1 2025 results, announced a quarterly dividend of $0.20/share, and provided guidance.
More LeMaitre Vascular, Inc. News

Company Profile

LeMaitre Vascular, Inc. engages in the provision of medical devices and human tissue cryopreservation services. The company focuses on the design, marketing, sales, service, and technical support of medical devices and implants for the treatment of peripheral vascular disease. Its products include balloon catheters, carotid shunts, biologic patches, radiopaque marking tape, anastomotic clips, remote endarterectomy devices, laparoscopic cholecystectomy devices, vascular grafts, and powered phlebectomy. The company was founded by George D. LeMaitre on November 28, 1983 and is headquartered in Burlington, MA.

Head office United States
CEO George LeMaitre
Employees 664
Founded 1983
Website www.lemaitre.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today